ENDRA Life Sciences Inc. (NDRA) › Operating IncomeENDRA Life Sciences Inc. (NDRA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$1.79M2017: -$4.63M2018: -$9.02M2019: -$10.84M2020: -$11.50M2021: -$11.50M2022: -$13.16M2023: -$10.52M2024: -$10.82M2025: -$5.76M-$5.76M2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$5.76M+46.7%2024-$10.82M-2.8%2023-$10.52M+20.0%2022-$13.16M-14.4%2021-$11.50M+0.0%2020-$11.50M-6.1%2019-$10.84M-20.2%2018-$9.02M-95.0%2017-$4.63M-158.2%2016-$1.79M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share